Organigram Holdings Inc. (OGI)
| Market Cap | 161.71M |
| Revenue (ttm) | 115.45M |
| Net Income (ttm) | -36.59M |
| Shares Out | 126.22M |
| EPS (ttm) | -0.35 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,095,554 |
| Open | 1.290 |
| Previous Close | 1.290 |
| Day's Range | 1.240 - 1.314 |
| 52-Week Range | 1.240 - 2.910 |
| Beta | 1.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 11, 2025 |
About OGI
Organigram Holdings Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plan... [Read more]
Financial Performance
In 2024, Organigram Holdings's revenue was 159.84 million, an increase of 7.13% compared to the previous year's 149.21 million. Losses were -45.44 million, -80.20% less than in 2023.
Financial numbers in CAD Financial StatementsNews
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Confere...
Organigram Reports First Quarter Fiscal 2025 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended...
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, a...
Organigram: Long Term Growth Improving With International And Domestic Cannabis Expansion (Rating Upgrade)
Organigram reported Q4-2024 financial results earlier this week and show improved revenues, profit margins, net loss, and increased cash. The company announced the acquisition of Canadian private cann...
Organigram Holdings Inc. (OGI) Q4 2024 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guy...
Canada's Organigram shops for U.S. pot businesses with backing from British American Tobacco
Legal cannabis company grows revenue and narrows its loss as it continues its acquisition push.
Organigram Reports Fourth Quarter and Fiscal 2024 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer (“LP”) of cannabis, announced its results for the fourth quart...
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, a...
OrganiGram purchasing Motif Labs to become Canada's largest cannabis company by market share, as others retreat
OrganiGram to pay up to C$100 million ($70.7 million) for vape and prerolled cannabis specialist Motif.
Organigram Acquires Motif, Becoming Canada's Largest Cannabis Company by Market Share
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce the acquisition of 100% of...
Organigram Could Soar In 2026
Organigram's stock is undervalued, trading at a 22% discount to tangible book value, with strong growth projections and a solid financial outlook. The company has a high cash balance and no debt, bols...
Hemp-based THC revenue may make cannabis stocks more appealing—but there are risks
With cannabis stocks showing steep losses this year on stalled legalization on the U.S. federal level, some companies in the sector are turning to the more thinly-regulated business of THC derived fro...
Organigram Launches FAST™ Nanoemulsion Gummies
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is thrilled to finally launch Edison Sonics gummi...
Organigram: Why I Still Like It
Organigram's stock has surged 22% since my last analysis, outperforming the cannabis market, yet it remains a buy due to its promising chart and valuation. The fiscal Q3 report exceeded expectations w...
3 Marijuana Stocks To Watch In The Stock Market Today
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the can...
CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology
SACRAMENTO, Calif.--(BUSINESS WIRE)--CPS HR Consulting, a leader in public sector HR consulting, is thrilled to announce a strategic partnership with GovInvest, the pioneer of compensation analytics t...
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on August 30, 2024, the Comp...
Top Canadian Marijuana Stocks To Watch In 2024
When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things...
Next Week's Top Marijuana Stocks: Recent Big Gainers to Watch
The cannabis industry is buzzing with recent developments that could significantly impact its future. In July 2024, the U.S. Senate reintroduced the SAFE Banking Act to provide cannabis businesses wit...
Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)
Organigram reported improved 3Q 2024 results. The company holds lead position in the Canadian cannabis market and is increasing its international cannabis exports. OGI stock price trades below its NAV...
Organigram Holdings Inc. (OGI) Q3 2024 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI) Q3 2024 Earnings Conference Call August 13, 2024 8:00 AM ET Company Participants Max Schwartz - Director of Investor Relations Beena Goldenberg - Chief Executive...
Organigram's stock rises as Canadian pot company's revenue tops analyst estimate
OrganiGram Holdings Inc.'s stock OGI, -2.04% was up 4% in premarket trading Wednesday after the Canadian cannabis producer reported beter-than-expected revenue. OrganiGram swung to third-quarter net i...
Organigram Reports Third Quarter Fiscal 2024 Results
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended...
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, is pleased to unveil the preliminary results of its landmark clinical pharmacokine...